Yeast treatment may affect warfarin therapy
Posted on: Thursday, 2 March 2006, 11:27 CST
NEW YORK (Reuters Health) - For women taking warfarin to prevent blood clots, a single dose of fluconazole to treat a vaginal yeast infection can lead to an increased risk of bleeding, findings from a small study suggest.
The time taken for blood to clot -- the so-called prothrombin time -- should therefore be carefully monitored in this scenario, and a change in warfarin dose may be needed, the author advises.
Fluconazole (brand name, Diflucan) is a common treatment for vaginal candidiasis, and is known to interact with a number of drugs, including warfarin -- which can give rise to serious bleeding complications -- according to the report in the medical journal Obstetrics and Gynecology.
While a few studies have looked at the effect of several days of fluconazole therapy on bleeding risk in warfarin users, until now none had looked at the impact of a single dose.
The study involved six women who had been on warfarin therapy for at least 6 months and had no dose changes in the last 4 weeks. Prothrombin time and other blood-clotting measurements were taken at the start of the study and then repeated 2, 5, and 8 days after the participants took one 150-milligram dose of fluconazole.
Prothrombin times increased by 11 percent, 34 percent and 2 percent at each time point, respectively, Dr. Mark A. Turrentine, from the Kelsey-Seybold Clinic in Houston, found.
Following the fluconazole dose, three of the women required a decrease in warfarin dose.
Because the difference between a dangerous dose and an effective dose of warfarin is so narrow, and given the "individual sensitivity demonstrated by a portion of the population, some alteration of the dose of warfarin may be necessary when patients are given even a single dose of fluconazole," Turrentine concludes.
SOURCE: Obstetrics and Gynecology, February 2006.
Source: REUTERS
Related Articles
- Research Highlights New Approaches to Prevent Blood Clots in Several High-Risk Patient Populations Including Largest Study Ever to Examine Use of Blood-Thinning Medication in Patients With Cancer
- Kaiser Permanente Study Shows One in Seven Women Are Depressed Before, During, or After Pregnancy
- Palatin Technologies, Inc. Reports Positive Data From an At-Home Study of Pre- and Postmenopausal Women With Female Sexual Arousal Disorder Treated With Bremelanotide
- Study Eyes Diabetes in Pregnant Women
- Low-Dose Aspirin Did Not Prevent Cancer in Healthy Women/COMMENTARY
- Coffee Might Help Women's Blood Pressure
- Osta Biotechnologies Announces Promising Interim Results From Its Second Clinical Study on the Development of a Novel Blood Test for Osteoporosis
- Treat Fast, Get Results -- Two Studies of Poor, Low-Income Women Show Gains After Tests for Cervical Cancer
- Study: Aspirin Prevents Strokes in Women
- Study Suggests People Use at Home Blood Pressure Tests
 |
 |
User Comments (0)
RSS Feeds